KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Shares Issued: 2013-2024

Historic Shares Issued for Xenon Pharmaceuticals (XENE) over the last 12 years, with Dec 2024 value amounting to $12.1 million.

  • Xenon Pharmaceuticals' Shares Issued was N/A to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year change of. This contributed to the annual value of $12.1 million for FY2024, which is 96.58% down from last year.
  • Xenon Pharmaceuticals' Shares Issued amounted to $12.1 million in FY2024, which was down 96.58% from $353.5 million recorded in FY2023.
  • In the past 5 years, Xenon Pharmaceuticals' Shares Issued registered a high of $353.5 million during FY2023, and its lowest value of $82,000 during FY2020.
  • Over the past 3 years, Xenon Pharmaceuticals' median Shares Issued value was $277.8 million (recorded in 2022), while the average stood at $214.4 million.
  • Per our database at Business Quant, Xenon Pharmaceuticals' Shares Issued crashed by 99.70% in 2020 and then soared by 106,733.08% in 2022.
  • Yearly analysis of 5 years shows Xenon Pharmaceuticals' Shares Issued stood at $82,000 in 2020, then surged by 217.07% to $260,000 in 2021, then soared by 106,733.08% to $277.8 million in 2022, then increased by 27.26% to $353.5 million in 2023, then slumped by 96.58% to $12.1 million in 2024.